Ligand Pharmaceuticals
Ligand Pharmaceuticals Incorporated, a biotechnology company, focuses on the discovery and early-stage development of pharmaceuticals for.
Launch date
Employees
Market cap
$1.9b
Enterprise valuation
$1.7b (Public information from Sep 2024)
Share price
$105.01 LGND
San Diego California (HQ)
No columns specified